Digital Health Hong Kong

Hong Kong Artificial Intelligence (AI) in Life Sciences Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Hong Kong Artificial Intelligence (AI) in Life Sciences Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End-user, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.5 Mn Placeholder estimate
Estimate 2025 $5.7 Mn 0.2% of the global market
Projected 2034 $51.5 Mn 803.1% Adds $45.8 Mn over 9 forecast years
CAGR 2025–2034 27.7% Faster than 85% of 103 Digital Health markets here
Key players 10 +5
  • Hong Kong is 0.16% of the global market.
  • In APAC, the largest is China at $290.7 Mn.
  • Fastest growing: India at 29.7% a year.
  • Hong Kong ranks 6th of 9 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$45.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Artificial Intelligence (AI) in Life Sciences Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.5 Mn — —
2025 (base) $5.7 Mn +$1.2 Mn —
2026 (forecast) $7.3 Mn +$1.6 Mn +27.7%
2027 (forecast) $9.3 Mn +$2.0 Mn +63.1%
2028 (forecast) $11.9 Mn +$2.6 Mn +108.2%
2029 (forecast) $15.2 Mn +$3.3 Mn +165.9%
2030 (forecast) $19.4 Mn +$4.2 Mn +239.6%
2031 (forecast) $24.8 Mn +$5.4 Mn +333.7%
2032 (forecast) $31.6 Mn +$6.9 Mn +453.8%
2033 (forecast) $40.4 Mn +$8.8 Mn +607.2%
2034 (forecast) $51.5 Mn +$11.2 Mn +803.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Hong Kong Artificial Intelligence (AI) in Life Sciences Market Analysis at a glance
Market size, 2025$5.7 Mn placeholder estimate
Forecast, 2034$51.5 Mn placeholder estimate
Growth (CAGR), 2025–203427.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end-user (see all)
Key playersIBM Watson Health, Google Health, Microsoft Healthcare, Amazon Web Services (AWS), NVIDIA Corporation and 5 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong Artificial Intelligence (AI) in Life Sciences Market Analysis Executive Summary

AI in Lifesciences field refers to the application of sophisticated software programs to process big-data, and coming up with an accurate prediction of the outcome or the results, as well as improving the efficacy of the heath-care practitioners’ decisions. AI incorporates a broad definition of intelligent systems and machines whereas ML is a subset of AI, which is the system that can learn from experience. It is used to improve such aspects as the prognosis of patient outcomes, in diagnosis with the help of images, in drug development, in individual approaches to treatment.

In the global level, the integrated use of Artificial Intelligence in health facilities is growing. COVID-19 boosted the use of AI as an enabler and a solution to address the healthcare challenges such as telemedicine, patient care, and resources allocation. According to a McKinsey’s poll, 58% of the leaders of healthcare organizations seek application of artificial intelligence to enhance productivity and the level of services delivered to the patients.

Secondly, the World Health Organization points that the application of AI technologies will be useful for the lifescience industry since it allows increasing the outcomes of diagnostics and treatment. Mainly, due to the raising awareness of establishments in the healthcare industry regarding the importance of using AI and ML for enhancing the quality of clinical decisions and organization, the utilization of these technologies is expected to grow rapidly, opening new opportunities for developing progressive strategies to enhance the quality of healthcare on a worldwide basis.

Bar chart: Hong Kong AI in Life Sciences market size, 2024–2034, placeholder estimates. $4.5 Mn in 2024, $5.7 Mn in 2025 and $51.5 Mn in 2034, 27.7% CAGR.
Hong Kong AI in Life Sciences market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Market Dynamics for Artificial Intelligence (AI) in Life Sciences Market in Hong Kong

Market Growth Drivers

Several healthcare organisations have pushed for the integration of AI and embracing the use of ML due to its benefits on clinical decision making, patient satisfaction not forgetting the curtailing on administrative tasks. McKinsey and Company stated a report which showed that of health care leaders, 58% of them express their willing to embrace AI to enhance operational productivity as well as the quality of patient care. The advancement of the AI technologies has however been boosted by the COVID-19 pandemic as healthcare providers conduct virtual consultations using the AI technology and also managing the patients. Also, WHO stresses the need to increase the use of AI in the healthcare sector to improve the diagnostic and therapeutic outcomes. Many healthcare organizations are becoming aware of the growing role of AI and ML in providing precise treatment, decreasing costs, and enhancing productivity, and thus the usage is gradually set to rise in the next few years.

Opportunity

The competition within the industry is gradually tightening owing to such entrants as Zebra Medical Vision that mostly deals with the analytics of medical images through artificial intelligence. There are also policies which are also being developed in the course of reformations as the various regulatory authorities are developing standards for the introduction of AI in clinical environments. These developments will increase diagnostic correctness and eminence of the treatment processes creating AI & ML foundational components of future healthcare facilities.

Market Restraints

Despite the fact that AI have tremendous potential in lifesciences, there are certain obstacles that prevent them from garnering more attention. Among them is the trouble of finding qualified personnel that would be able to successfully incorporate these technologies and assess them within the current work setting. Also, ethical issues surrounding data protection, ownership, and algorithms’ prejudice remain prevalent, especially given the nature of medical data. Although lifescience is a huge market already saturated with advanced technologies, the integration of new AI systems with existing and dated healthcare IT systems is another issue. In addition, there is still no specific legislation and reimbursement strategies to dictate the application of AI-based medical devices to healthcare providers and manufacturers

Competitive Landscape for Artificial Intelligence (AI) in Life Sciences Market in Hong Kong

Key Players

Recent Developments

June 2024, Stanford Medicine computer scientists and physicians have recently unveiled a new AI tool capable of identifying diseased cells under the microscope, offering customization options for any pathologist. This development from Stanford Medicine will significantly impact digital pathology by enhancing diagnostic accuracy and efficiency

Mergers and Acquisitions

June 2024, Viz.ai, an AI stroke detection company, acquired Brainomix, a provider of AI-powered imaging solutions for stroke and cardiovascular diseases. The combined entity will offer a comprehensive platform for the diagnosis and treatment of stroke, leveraging advanced AI and machine learning techniques

March 2024, Zebra Medical Vision, an AI radiology startup, was acquired by Nanox, a provider of medical imaging systems. The acquisition aims to integrate Zebra's AI-powered imaging analytics into Nanox's cloud-based platform, enabling more accurate and efficient diagnosis of medical conditions

Healthcare Policies and Regulatory Landscape for Artificial Intelligence (AI) in Life Sciences Market in Hong Kong

Artificial Intelligence (AI) in Life Sciences in Hong Kong: payment

Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[1]

[1] Hospital Authority. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

There have been efforts to design and implement healthcare policies as well as regulations for AI to suit the problems they present. The FDA of United States, the European Commission and other regulatory authorities of the world are toil to come up with the guidelines for the safe jurisdiction of AI in health care sector. Currently, FDA is contemplating on the concept of “predetermined change control plan” whereby an AI system can change to other paths that have been predicted as allowed by change control plans without having to stick to re-authorization processes. This approach is intended to promote development of new care models as well as preserve patients’ safety.

Concerning the reimbursement of costs, there has been an increasing trend of awareness that insurance coverage policies should encompass AI-driven solutions. Currently, there are many recent legislative actions like the Better Mental Health Care for Americans Act that contends that all institutions operating in the health sector must make the decision-making processes of AI as transparent as possible while at the same time detailing the limitations of the treatment with the use of this technology. Also, the World Health organization has provided guidelines of ethical use of AI in the delivery of life science such that risks such as bias and issues to do with privacy are prevented.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Artificial Intelligence (AI) in Life Sciences right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Artificial Intelligence (AI) in Life Sciences in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 18 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the AI in Life Sciences market in Hong Kong?
Placeholder estimate: about $5.7 Mn in 2025, rising to about $51.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI in Life Sciences market in Hong Kong growing?
Placeholder estimate: about 27.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI in Life Sciences market report cover?
The report splits the market by technology (Machine Learning, Natural Language Processing, Image Recognition, Speech Recognition), application (Diagnostics, Drug Discovery, Personalized Medicine, Clinical Trials and more) and end-user (Pharmaceutical and Biotechnology Companies, Healthcare Payers, Research Laboratories).
Who are the key players in the AI in Life Sciences market?
Key players include IBM Watson Health, Google Health, Microsoft Healthcare, Amazon Web Services (AWS), NVIDIA Corporation and GE Healthcare, among 10 companies the report profiles.
What is driving the AI in Life Sciences market?
Several healthcare organisations have pushed for the integration of AI and embracing the use of ML due to its benefits on clinical decision making, patient satisfaction not forgetting the curtailing on administrative tasks.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
Back to Catalogue

Related Digital Health reports in Hong Kong

See all

Related on artificial intelligence and genomics

See the topic